4 cancer drugs in shortage: When drugmakers expect supply to rebound
Cisplatin, carboplatin, oxaliplatin and ifosfamide remain in active shortage, and manufacturers’ latest estimates show full resupply of some formulations will not arrive until October. Becker's Hospital Review